Using Prazosin to Treat Posttraumatic Stress Disorder and Associations: A Systematic Review

키워드

참고문헌 (45)

1. Cabizuca M, "The invisible patients : posttraumatic stress disorder in parents of individuals with cystic fibrosis", Rev Psiq Clín, 37, pp.6~11 (2010)
2. Spottswood M, "The prevalence of posttraumatic stress disorder in primary care : a systematic review", Harv Rev Psychiatry, 25, pp.159~169 (2017)
3. Writer BW, "Prazosin for military CombatRelated PTSD Nightmares : a critical review", J Neuropsychiatry Clin Neurosci, 26, pp.24~33 (2014)
4. Kolk BA, "Dissociation, somatization, and affect dysregulation: the complexity of adaptation of trauma", Am J Psychiatry, 153(7 Suppl), pp.83~93 (1996)
5. Koenen KC, "Posttraumatic stress disorder in the World Mental Health Surveys", Psychol Med, 47, pp.2260~2274 (2017)
6. Kilpatrick DG, "National estimates of exposure to traumatic events and PTSD prevalence using DSM-IV and DSM-5 criteria", J Trauma Stress, 26, pp.537~547 (2013)
7. Van Ameringen M, "Post-traumatic stress disorder in Canada", CNS Neurosci Ther, 14, pp.171~181 (2008)
8. Sareen J, "Posttraumatic stress disorder in adults : impact, comorbidity, risk factors, and treatment", Can J Psychiatry, 59, pp.460~467 (2014)
9. Schestatsky S, "Historical evolution of the concept of posttraumatic stress disorder", Braz J Psychiatry, 25(Suppl I), pp.8~11 (2003)
10. Lifton RJ, "The human meaning of total disaster. The Buffalo Creek Experience", Psychiatry, 39, pp.1~18 (1976)
11. Geracioti TD, "CSF norepinephrine concentrations in posttraumatic stress disorder", Am J Psychiatry, 158, pp.1227~1230 (2001)
12. Hendrickson RC, "Noradrenergic dysregulation in the pathophysiology of PTSD", Exp Neurol, 284, pp.181~195 (2016)
13. Boehnlein JK, "Pharmacologic reduction of CNS noradrenergic activity in PTSD : the case for clonidine and prazosin", J Psychiatr Pract, 13, pp.72~78 (2007)
14. Lydiard RB, "Clinical importance of sleep disturbance as a treatment target in PTSD", Spring, 7, pp.176~183 (2009)
15. Schoenfeld FB, "Treatment of sleep disturbances in posttraumatic stress disorder : a review", J Rehabil Res Dev, 49, pp.729~752 (2012)
16. Sjöström N, "Persistent nightmares are associated with repeat suicide attempt : a prospective study", Psychiatry Res, 170, pp.208~211 (2009)
17. Liempt S, "Pharmacotherapy for disordered sleep in posttraumatic stress disorder : a systematic review", Int Clin Psychopharmacol, 21, pp.193~202 (2006)
18. El-Solh AA, "Management of nightmares in patients with posttraumatic stress disorder : current perspectives", Nat Sci Sleep, 10, pp.409~420 (2018)
19. George KC, "Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder", J Trauma Dissociation, 17, pp.494~510 (2016)
20. Raskind MA, "The alpha1-adrenergic antagonist prazosin ameliorates combat trauma nightmares in veterans with posttraumatic stress disorder : a report of 4 cases", J Clin Psychiatry, 61, pp.129~134 (2000)
21. Raskind MA, "Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder", J Clin Psychiatry, 63, pp.565~568 (2002)
22. Taylor F, "The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder", J Clin Psychopharmacol, 22, pp.82~85 (2002)
24. Peskind ET, "Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder", J Geriatr Psychiatry Neurol, 16, pp.165~171 (2003)
25. Raskind MA, "Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin : a placebo-controlled study", Am J Psychiatry, 160, pp.371~373 (2003)
26. Taylor FB, "Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder", Biol Psychiatry, 59, pp.577~581 (2006)
27. Taylor FB, "Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder : a placebo-controlled study", Biol Psychiatry, 63, pp.629~632 (2008)
28. Raskind MA, "A parallel group placebo-controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder", Biol Psychiatry, 61, pp.928~934 (2007)
29. Germain A, "Placebo-controlled comparison of prazosin and cognitivebehavioral treatments for sleep disturbances in US Military Veterans", J Psychosom Res, 72, pp.89~96 (2012)
30. Raskind MA, "A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan", Am J Psychiatry, 170, pp.1003~1010 (2013)
31. Ahmadpanaha M, "Comparing the effect of prazosin and hydroxyzine on sleep quality in patients suffering from posttraumatic stress disorder", Neuropsychobiology, 69, pp.235~242 (2014)
32. De Berardis D, "Targeting the noradrenergic system in posttraumatic stress disorder : a systematic review and meta-analysis of prazosin trials", Curr Drug Targets, 16, pp.1094~1106 (2015)
33. Seda G, "Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmare frequency, sleep quality, and posttraumatic stress", J Clin Sleep Med, 11, pp.11~22 (2015)
34. Khachatryan D, "Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder : a systematic review and meta-analysis of randomized controlled trials", Gen Hosp Psychiatry, 39, pp.46~52 (2016)
35. Raskind MA, "Trial of prazosin for post-traumatic stress disorder in military veterans", N Engl J Med, 378, pp.507~517 (2018)
36. Glue P, "Prazosin for post-traumatic stress disorder", N Engl J Med, 378, pp.1649~ (2018)
37. McCall WV, "A pilot, randomized clinical trial of bedtime doses of prazosin versus placebo in suicidal posttraumatic stress disorder patients with nightmares", J Clin Psychopharmacol, 38, pp.618~621 (2018)
38. Singh B, "Efficacy of prazosin in posttraumatic stress disorder : a systematic review and metaanalysis", Prim Care Companion CNS Disord, 18 (2016)
39. Green B, "Prazosin in the treatment of PTSD", J Psychiatr Pract, 20, pp.253~259 (2014)
40. Breen A, "The efficacy of prazosin for the treatment of posttraumatic stress disorder nightmares in U. S. military veterans", J Am Assoc Nurse Pract, 29, pp.65~69 (2017)
41. Simon PY, "Treatment of post-traumatic stress disorders with the alpha-1 adrenergic antagonist prazosin", Can J Psychiatry, 62, pp.186~198 (2017)
42. Akinsanya A, "Prazosin in children and adolescents with posttraumatic stress disorder who have nightmares : a systematic review", J Clin Psychopharmacol, 37, pp.84~88 (2017)
43. Khaw C, "Prazosin initiation and dose titration in a patient with posttraumatic stress disorder on concurrent carvedilol", Ment Health Clin, 9, pp.326~330 (2019)
44. McCall WV, "Bedtime doses of prazosin do not affect daytime salivary amylase markers in PTSD", Heliyon, 5, pp.e01709~ (2019)
45. Verplaetse TL, "Alcohol abstainer status and prazosin treatment in association with changes in posttraumatic stress disorder symptoms in veterans with comorbid alcohol use disorder and posttraumatic stress disorder", Alcohol Clin Expl Res, 43, pp.741~746 (2019)

관련 논문AI추천